Concepts (136)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Acute Kidney Injury | 8 | 2021 | 1943 | 1.350 |
Why?
|
Kidney Diseases | 2 | 2023 | 2100 | 0.760 |
Why?
|
Exosomes | 2 | 2022 | 417 | 0.690 |
Why?
|
Kidney | 8 | 2023 | 7072 | 0.670 |
Why?
|
Reperfusion Injury | 3 | 2023 | 1043 | 0.620 |
Why?
|
Renin-Angiotensin System | 1 | 2021 | 736 | 0.530 |
Why?
|
T-Lymphocyte Subsets | 3 | 2020 | 1814 | 0.520 |
Why?
|
Multiple Organ Failure | 1 | 2018 | 389 | 0.500 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2021 | 1060 | 0.460 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2021 | 1513 | 0.460 |
Why?
|
Antihypertensive Agents | 1 | 2021 | 2028 | 0.380 |
Why?
|
Immunity, Cellular | 1 | 2017 | 1557 | 0.370 |
Why?
|
Mesenchymal Stem Cells | 1 | 2022 | 1663 | 0.360 |
Why?
|
Ischemia | 1 | 2019 | 1904 | 0.360 |
Why?
|
Crohn Disease | 1 | 2023 | 2281 | 0.360 |
Why?
|
Parathyroid Hormone | 1 | 2016 | 1790 | 0.330 |
Why?
|
Cerebrovascular Disorders | 1 | 2016 | 1478 | 0.320 |
Why?
|
Kidney Failure, Chronic | 3 | 2016 | 2504 | 0.320 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2023 | 2431 | 0.310 |
Why?
|
Monocytes | 1 | 2018 | 2591 | 0.310 |
Why?
|
Cause of Death | 1 | 2018 | 3715 | 0.290 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2019 | 4408 | 0.280 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2017 | 2306 | 0.240 |
Why?
|
Critical Illness | 1 | 2018 | 2749 | 0.240 |
Why?
|
Histocompatibility Antigens Class II | 2 | 2019 | 1441 | 0.230 |
Why?
|
Carcinoma, Renal Cell | 1 | 2018 | 3186 | 0.210 |
Why?
|
Kidney Neoplasms | 1 | 2018 | 4282 | 0.190 |
Why?
|
NF-E2-Related Factor 2 | 2 | 2023 | 385 | 0.160 |
Why?
|
Kidney Tubules, Proximal | 1 | 2020 | 386 | 0.150 |
Why?
|
Creatinine | 1 | 2023 | 1916 | 0.150 |
Why?
|
Spleen | 1 | 2023 | 2294 | 0.140 |
Why?
|
Adoptive Transfer | 1 | 2020 | 827 | 0.140 |
Why?
|
Antioxidants | 2 | 2023 | 1671 | 0.140 |
Why?
|
Disease Models, Animal | 5 | 2020 | 18321 | 0.140 |
Why?
|
Antigens, Ly | 1 | 2018 | 297 | 0.140 |
Why?
|
Renal Dialysis | 2 | 2016 | 1791 | 0.130 |
Why?
|
Mice, Inbred C57BL | 5 | 2021 | 22341 | 0.120 |
Why?
|
Tuberculosis, Pleural | 1 | 2015 | 14 | 0.120 |
Why?
|
Bicarbonates | 1 | 2016 | 293 | 0.120 |
Why?
|
Nephrosis, Lipoid | 1 | 2015 | 46 | 0.120 |
Why?
|
Glomerular Filtration Rate | 1 | 2023 | 2232 | 0.120 |
Why?
|
Antigens, Surface | 1 | 2019 | 1616 | 0.110 |
Why?
|
Antibiotics, Antitubercular | 1 | 2015 | 100 | 0.110 |
Why?
|
Peritoneal Dialysis | 1 | 2015 | 161 | 0.110 |
Why?
|
Cisplatin | 1 | 2020 | 1654 | 0.110 |
Why?
|
Up-Regulation | 2 | 2019 | 4133 | 0.110 |
Why?
|
Cardiovascular Diseases | 2 | 2016 | 15647 | 0.110 |
Why?
|
Nephrectomy | 1 | 2018 | 928 | 0.100 |
Why?
|
Rifampin | 1 | 2015 | 350 | 0.100 |
Why?
|
Ferritins | 1 | 2015 | 600 | 0.100 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2039 | 0.100 |
Why?
|
Fibronectins | 1 | 2015 | 721 | 0.100 |
Why?
|
Interferon-gamma | 1 | 2019 | 3159 | 0.090 |
Why?
|
Hematopoietic Stem Cells | 1 | 2023 | 3405 | 0.090 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2020 | 2570 | 0.090 |
Why?
|
Sarcopenia | 1 | 2015 | 378 | 0.090 |
Why?
|
T-Lymphocytes | 2 | 2018 | 10260 | 0.080 |
Why?
|
Cells, Cultured | 3 | 2020 | 18967 | 0.080 |
Why?
|
Lymphocytes | 1 | 2017 | 2602 | 0.080 |
Why?
|
Surgical Procedures, Operative | 1 | 2020 | 1931 | 0.080 |
Why?
|
Carotid Artery Diseases | 1 | 2015 | 872 | 0.080 |
Why?
|
Odds Ratio | 1 | 2021 | 9657 | 0.080 |
Why?
|
Mice | 6 | 2023 | 81839 | 0.080 |
Why?
|
Animals | 8 | 2023 | 168800 | 0.070 |
Why?
|
Epithelial Cells | 1 | 2020 | 3684 | 0.070 |
Why?
|
Humans | 15 | 2023 | 766117 | 0.070 |
Why?
|
Mice, Knockout | 2 | 2019 | 14456 | 0.070 |
Why?
|
Bacterial Infections | 1 | 2015 | 1387 | 0.070 |
Why?
|
Male | 9 | 2021 | 363935 | 0.060 |
Why?
|
Risk Factors | 5 | 2021 | 74857 | 0.060 |
Why?
|
Databases, Factual | 1 | 2021 | 8062 | 0.060 |
Why?
|
Survival Analysis | 1 | 2018 | 10087 | 0.060 |
Why?
|
Mortality | 1 | 2016 | 2911 | 0.060 |
Why?
|
Immunotherapy | 1 | 2020 | 4746 | 0.060 |
Why?
|
Neutrophils | 1 | 2017 | 3771 | 0.060 |
Why?
|
Apoptosis | 1 | 2020 | 9508 | 0.060 |
Why?
|
Glutamate-Cysteine Ligase | 1 | 2023 | 24 | 0.050 |
Why?
|
Comorbidity | 1 | 2018 | 10579 | 0.050 |
Why?
|
Liver | 1 | 2018 | 7559 | 0.050 |
Why?
|
Cell Differentiation | 1 | 2019 | 11642 | 0.050 |
Why?
|
Antigens, CD34 | 1 | 2023 | 656 | 0.050 |
Why?
|
Hospitalization | 1 | 2021 | 10811 | 0.050 |
Why?
|
Aged | 6 | 2021 | 171219 | 0.040 |
Why?
|
Cardiac Surgical Procedures | 1 | 2016 | 3682 | 0.040 |
Why?
|
Prognosis | 2 | 2018 | 29912 | 0.040 |
Why?
|
Disease Progression | 1 | 2017 | 13616 | 0.040 |
Why?
|
Lung | 1 | 2018 | 10063 | 0.040 |
Why?
|
Female | 7 | 2021 | 396233 | 0.040 |
Why?
|
Middle Aged | 5 | 2021 | 223083 | 0.040 |
Why?
|
NAD(P)H Dehydrogenase (Quinone) | 1 | 2018 | 57 | 0.040 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13635 | 0.040 |
Why?
|
Jurkat Cells | 1 | 2018 | 738 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2020 | 1336 | 0.030 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2018 | 893 | 0.030 |
Why?
|
Heme Oxygenase-1 | 1 | 2018 | 364 | 0.030 |
Why?
|
Lectins, C-Type | 1 | 2018 | 592 | 0.030 |
Why?
|
Random Allocation | 1 | 2019 | 2395 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2016 | 15808 | 0.030 |
Why?
|
Flow Cytometry | 1 | 2023 | 5881 | 0.030 |
Why?
|
Kidney Function Tests | 1 | 2015 | 684 | 0.030 |
Why?
|
Kidney Glomerulus | 1 | 2015 | 567 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2018 | 1181 | 0.020 |
Why?
|
Arm | 1 | 2015 | 590 | 0.020 |
Why?
|
Proteinuria | 1 | 2015 | 606 | 0.020 |
Why?
|
Interleukin-2 | 1 | 2019 | 1894 | 0.020 |
Why?
|
Nausea | 1 | 2015 | 679 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2023 | 3140 | 0.020 |
Why?
|
Neoplasms | 1 | 2020 | 22344 | 0.020 |
Why?
|
Reference Values | 1 | 2019 | 4909 | 0.020 |
Why?
|
Brain | 1 | 2018 | 27177 | 0.020 |
Why?
|
Edema | 1 | 2015 | 763 | 0.020 |
Why?
|
Anthropometry | 1 | 2015 | 1339 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2824 | 0.020 |
Why?
|
Remission Induction | 1 | 2015 | 2413 | 0.020 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2015 | 3801 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2019 | 5503 | 0.020 |
Why?
|
Antigens, CD | 1 | 2018 | 4025 | 0.020 |
Why?
|
Adult | 3 | 2016 | 223139 | 0.020 |
Why?
|
Nutritional Status | 1 | 2015 | 1620 | 0.020 |
Why?
|
Coronary Artery Bypass | 1 | 2016 | 2188 | 0.020 |
Why?
|
Inflammation | 2 | 2015 | 10860 | 0.020 |
Why?
|
Gene Expression | 1 | 2018 | 7582 | 0.020 |
Why?
|
Cell Proliferation | 1 | 2020 | 10433 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2019 | 14645 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2018 | 12775 | 0.010 |
Why?
|
Length of Stay | 1 | 2016 | 6490 | 0.010 |
Why?
|
Phenotype | 1 | 2020 | 16716 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2018 | 17071 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12529 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15882 | 0.010 |
Why?
|
Body Mass Index | 1 | 2015 | 13046 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2015 | 22228 | 0.010 |
Why?
|
Incidence | 1 | 2016 | 21513 | 0.010 |
Why?
|
Cohort Studies | 1 | 2015 | 41684 | 0.010 |
Why?
|
Prospective Studies | 1 | 2015 | 54812 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2015 | 65219 | 0.000 |
Why?
|
Concepts
(136)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_